Oral immunotherapy (OIT) represents a disease-modifying approach in the management of IgE-mediated food allergy, capable of reprogramming humoral immune responses and modulating both allergen-specific IgE levels and their downstream effector pathways [25]. The gene discussed is IGHE; the disease is food allergy.